Skip to main content
. 2017 Jun 13;6(6):e005562. doi: 10.1161/JAHA.117.005562

Figure 4.

Figure 4

Inhibition of platelet aggregation (IPA) with thrombin receptor activating peptide (TRAP). A, IPA with TRAP 10 μmol/L after treatment with ticagrelor and eptifibatide (T+E) bolus vs ticagrelor and eptifibatide bolus with 2‐hour infusion (T+E bolus and 2‐hour infusion). B, IPA with TRAP 20 μmol/L after treatment with ticagrelor and eptifibatide (T+E) bolus vs ticagrelor and eptifibatide bolus with 2‐hour infusion (T+E bolus and 2‐hour infusion). In both (A and B), IPA levels were significantly higher at 2 and 6 hours than 24 hours. IPA level was significantly higher with T+E bolus and 2‐hour infusion than with T+E at 6 hours.